tailieunhanh - JMJD2A participates in cytoskeletal remodeling to regulate castration-resistant prostate cancer docetaxel resistance

To investigate underlying mechanism of JMJD2A in regulating cytoskeleton remodeling in castrationresistant prostate cancer (CRPC) resistant to docetaxel. Tissue samples from CRPC patients were collected, and the expression of JMJD2A, miR-34a and cytoskeleton remodeling-related proteins were evaluated by qPCR, western blot and immunohistochemistry, and pathological changes were observed by H&E staining. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN